Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
38
GH Quote, Financials, Valuation and Earnings
Last price:
$47.29
Seasonality move
:
-9.62%
Day range:
$47.30 - $48.99
52-week range:
$20.14 - $53.42
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.62x
P/B ratio:
32.59x
Volume:
1.5M
Avg. volume:
2.1M
1-year change:
41.32%
Market cap:
$5.9B
Revenue:
$739M
EPS (TTM):
-$3.39
Earnings Data
Next earnings date for GH
Jul 30
2025
Most recent earnings per share
-$0.77
Missed by $0.18
(Apr 30/2025)
Consensus Estimate
-$0.59
(Apr 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GH Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $226.4M | -- | -- | -$0.49 | -- |
| 07/30/2025 | Q2 | $211.3M | -- | -- | -$0.51 | -- |
| 04/30/2025 | Q1 | $190M | $203.5M | -$0.77 | -$0.59 | -$0.18 |
| 02/20/2025 | Q4 | $192.5M | $201.8M | -$0.90 | -$0.50 | -$0.40 |
| 11/06/2024 | Q3 | $170.6M | $191.5M | -$0.88 | -$0.60 | -$0.28 |
| 08/07/2024 | Q2 | $162.6M | $177.2M | -$0.84 | -$0.61 | -$0.23 |
| 05/09/2024 | Q1 | $149.8M | $168.5M | -$0.94 | -$0.73 | -$0.21 |
| 02/22/2024 | Q4 | $150.8M | $155.1M | -$1.58 | -$0.75 | -$0.83 |
| 11/06/2023 | Q3 | -- | -- | -$0.73 | -$0.80 | $0.07 |
| 08/03/2023 | Q2 | -- | -- | -$0.67 | -$0.93 | $0.26 |
| 05/09/2023 | Q1 | -- | -- | -$1.30 | -$1.07 | -$0.23 |
| 02/23/2023 | Q4 | -- | -- | -$1.36 | -$1.16 | -$0.20 |
| 11/03/2022 | Q3 | -- | -- | -$1.58 | -$1.08 | -$0.50 |
| 08/04/2022 | Q2 | -- | -- | -$2.25 | -$0.97 | -$1.28 |
| 05/05/2022 | Q1 | -- | -- | -$1.21 | -$1.10 | -$0.11 |
| 02/23/2022 | Q4 | -- | -- | -$0.89 | -$1.08 | $0.19 |
| 11/04/2021 | Q3 | -- | -- | -$1.06 | -$0.87 | -$0.19 |
| 08/05/2021 | Q2 | -- | -- | -$0.96 | -$0.83 | -$0.13 |
| 05/06/2021 | Q1 | -- | -- | -$1.09 | -$0.87 | -$0.22 |
| 02/24/2021 | Q4 | -- | -- | -$0.94 | -$0.47 | -$0.47 |
| 11/05/2020 | Q3 | -- | -- | -$0.78 | -$0.36 | -$0.42 |
| 08/06/2020 | Q2 | -- | -- | -$0.57 | -$0.36 | -$0.21 |
| 05/07/2020 | Q1 | -- | -- | -$0.29 | -$0.39 | $0.10 |
| 02/24/2020 | Q4 | -- | -- | -$0.27 | -$0.30 | $0.03 |
| 11/07/2019 | Q3 | -- | -- | -$0.14 | -$0.37 | $0.23 |
| 08/06/2019 | Q2 | -- | -- | -$0.13 | -$0.35 | $0.22 |
| 05/09/2019 | Q1 | -- | -- | -$0.30 | -$0.37 | $0.07 |
| 03/12/2019 | Q4 | -- | -- | -$0.30 | -$0.35 | $0.05 |
| 11/19/2018 | Q3 | -- | -- | -$0.29 | -$0.29 | $0.01 |
Guardant Health Earnings Questions
-
How Much did Guardant Health Generate in Revenue Last Quarter?
Guardant Health reported $203.5M worth of top line sales in its most recent quarter.
-
Did Guardant Health Beat Earnings Last Quarter?
Guardant Health announced earnings per share of -$0.77 which represents a miss of analyst forecast a -$0.59 per share.
-
Is Guardant Health Profitable?
Guardant Health reported $128.7M that represents $1.04 per share over the last quarter.
-
What is the Analyst Consensus for Guardant Health EPS Next Year?
Guardant Health's earnings are forecast to decrease from -$3.56 per share to -$1.99 per share next year representing a decrease of -43.91%.
-
When is Guardant Health's Earnings Date?
Guardant Health's next earnings date is July 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
